Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Cancer hijacks natural cell process to survive

News

Cancer tumours manipulate a natural cell process to promote their survival suggesting that controlling this mechanism could stop progress of the disease, according to new research led by the University of Oxford.

cancer cell process

Co-author Professor Christopher Yau said 'These investigations may pave the way to new treatment possibilities for NHS patients in the future.'

Read the full article

Similar stories

New vaccine trial for Middle East Respiratory Syndrome launched

A new clinical trial to find a vaccine to protect people against Middle East Respiratory Syndrome (MERS) launched on 15 September 2023. This is the third Phase I clinical trial of the ChAdOx1 MERS vaccine, developed by researchers at the Pandemic Sciences Institute. It is the first trial in older people.

Monitoring the current Nipah virus outbreak in India

Clinical trial for Crimean-Congo haemorrhagic fever vaccine launched

Six NDM researchers awarded Professorships

Impact of Ling’s legacy on CAMS Oxford Institute Researchers

CEPI and Oxford to accelerate vaccine development against Disease X